Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15
Original Research
Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,101 | Dovepress* | 3,022+ | 76 | 3,098 | |
| PubMed Central* | 79 | 48 | 127 | ||
| Totals | 3,101 | 124 | 3,225 | ||
| *Since 20 May 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar